Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Outset Medical Inc., 3 years.
Outset Medical Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2024 | Edwards Lifesciences Corporation | Grant or award | +10,910 | — | — |
| Sep 3, 2024 | Edwards Lifesciences Corporation | Shares withheld for tax | −5,530 | $69.96 | $386,879 |
| Jul 7, 2024 | Edwards Lifesciences Corporation | Shares withheld for tax | −258 | $92.32 | $23,819 |
| May 11, 2024 | Edwards Lifesciences Corporation | Shares withheld for tax | −827 | $86.72 | $71,717 |
| May 7, 2024 | Edwards Lifesciences Corporation | Grant or award | +32,025 | — | — |
| May 7, 2024 | Edwards Lifesciences Corporation | Shares withheld for tax | −609 | $85.09 | $51,820 |
| May 4, 2024 | Edwards Lifesciences Corporation | Option exercise | +5,796 | — | — |
| May 4, 2024 | Edwards Lifesciences Corporation | Shares withheld for tax | −3,442 | $85.25 | $293,431 |
| May 3, 2024 | Edwards Lifesciences Corporation | Shares withheld for tax | −479 | $85.06 | $40,744 |
| Feb 22, 2024 | Edwards Lifesciences Corporation | Grant or award | +8,560 | — | — |
| Feb 15, 2024 | Edwards Lifesciences Corporation | Option exercise | +27,000 | $36.75 | $992,250 |
| Feb 15, 2024 | Edwards Lifesciences Corporation | Open-market sale | −27,000 | $85.62 | $2,311,740 |
| Feb 13, 2024 | Edwards Lifesciences Corporation | Option exercise | +20,000 | $36.75 | $735,000 |
| Feb 13, 2024 | Edwards Lifesciences Corporation | Open-market sale | −20,000 | $86.46 | $1,729,200 |
| Oct 10, 2023 | Edwards Lifesciences Corporation | Option exercise | +5,000 | $36.75 | $183,750 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.